أسهم رأس المال العادية تغيير تاريخ
Agenus USD 38.52M 3.2M 2026-03
Alaunos Therapeutics USD 2.49M 108K 2026-06
Amgen USD 541M 0 2026-09
Anika Therapeutics USD 13.89M 532K 2025-12
Arrowhead Research USD 141.14M 564K 2026-06
AstraZeneca USD 1.55B 28K 2026-09
Bristol-Myers Squibb USD 2.04B 7M 2026-06
Gilead Sciences USD 1.24B 1000K 2026-06
GlaxoSmithKline GBP 2.02B 2.05B 2026-09
Heron Therapeutics USD 188.31M 4.99M 2025-12
Incyte USD 200.98M 1.03M 2026-06
Intrexon USD 0 0 2024-06
Karyopharm Therapeutics USD 22.54M 4.23M 2026-03
Ligand Pharmaceuticals USD 19.66M 19.64M 2025-09
MacroGenics USD 63.65M 86K 2026-06
MannKind USD 321.63M 11.72M 2026-09
Merck USD 2.47B 1.05M 2026-06
Novartis USD 1.89B 12.09M 2026-09
Rigel Pharmaceuticals USD 17K 158K 2024-06
Roche Holding CHF 796.77M 1.15M 2026-06
Thermo Fisher Scientific USD 369.75M 1.88M 2026-09
Veracyte USD 80.39M 598K 2026-09
Xencor USD 74.33M 265K 2026-06